Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Children unable to access precision medicine for cancer

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives €“ signalling a new era of precision medicine for young patients.

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives but only 7% of those with targetable mutations were able to access the appropriate adult drug. The pilot including more than 200 children found that half had gene mutations that are targetable by adult cancer drugs that are either available as standard treatment or via clinical trials – signalling a new era of precision medicine for young patients. Although few children on the study went on to receive adult drugs, those who did receive targeted therapies

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy